Therapeutic Areas

MEU is one of the leading clinical trial and research facilities in the UK with over 20 years’ experience in the industry. We have safely and efficiently completed over 370 clinical trials, involving over 10,000 patients during this period. We hold MHRA Phase I accreditation and our Phase I-IV studies cover numerous therapeutic indications and patient groups.


The MEU is recognised as the premier Phase I unit to undertake clinical trials in respiratory conditions, including Asthma and COPD, performing over 300 studies in this area.


The MEU has key opinion leaders in numerous areas within dermatology; such as Psoriasis and Atopic Dermatitis.


Our database has hundreds of patients with inflammatory conditions ranging from skin to rheumatological diseases.


The MEU database includes over 2,500 patients with cardiovascular conditions, highlighting an effective recruitment policy for patients in this area of medicine.


The MEU has a database of over 700 diabetes patients which allows for fast and responsive recruitment in this area.